These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 6873143

  • 21. Quantitative histophotometry analysing significant inductive and alterative effects of aminoglycoside application (gentamicin, tobramycin, amikacin) upon tubular kidney proteins.
    Heinert G, Wyrobnik J, Scherberich J, Mondorf W, Weber W.
    Urol Int; 1982; 37(4):221-35. PubMed ID: 6182668
    [Abstract] [Full Text] [Related]

  • 22. Comparative low-dose nephrotoxicities of gentamicin, tobramycin, and amikacin.
    Hottendorf GH, Gordon LL.
    Antimicrob Agents Chemother; 1980 Jul; 18(1):176-81. PubMed ID: 7416743
    [Abstract] [Full Text] [Related]

  • 23. Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods.
    Drasar FA, Farrell W, Maskell J, Williams JD.
    Br Med J; 1976 Nov 27; 2(6047):1284-7. PubMed ID: 1000196
    [Abstract] [Full Text] [Related]

  • 24. Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin.
    Reynolds AV, Hamilton-Miller JM, Brumfitt W.
    Br Med J; 1974 Sep 28; 3(5934):778-80. PubMed ID: 4213265
    [Abstract] [Full Text] [Related]

  • 25. Comparative pharmacokinetics of aminoglycoside antibiotics in guinea pigs.
    Chung M, Parravicini L, Assael BM, Cavanna G, Radwanski E, Symchowicz S.
    Antimicrob Agents Chemother; 1982 Dec 28; 22(6):1017-21. PubMed ID: 7159067
    [Abstract] [Full Text] [Related]

  • 26. [The distribution of aminoglycoside antibiotics into the lymph and pancreatic fluid in dogs (author's transl)].
    Lee YG.
    Jpn J Antibiot; 1980 May 28; 33(5):558-73. PubMed ID: 7431657
    [Abstract] [Full Text] [Related]

  • 27. [Clinical pharmacology of the most frequently used aminoglucosides: gentamycin, tobramycin and amikacin].
    Cuena Boy R, Azanza Perea JR, Echeverría Echepare LM, Honorato Pérez J.
    Rev Med Univ Navarra; 1983 Dec 28; 27(4):21-7. PubMed ID: 6676898
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Changes in the apparent half life of gentamicin and tobramycin without detectable changes in creatinine clearance.
    Vozeh S, Spring P, Wenk M, Follath F.
    Br J Clin Pharmacol; 1979 Jun 28; 7(6):629-31. PubMed ID: 465287
    [No Abstract] [Full Text] [Related]

  • 30. Control of emergence of multi-resistant gram-negative bacilli by exclusive use of amikacin.
    Ruiz-Palacios GM, Ponce de Leon S, Sifuentes J, Ponce de Leon S, Calva JJ, Huazano F, Ontiveros C, Ojeda F, Bobadilla M.
    Am J Med; 1986 Jun 30; 80(6B):71-5. PubMed ID: 3089006
    [Abstract] [Full Text] [Related]

  • 31. Resistance to gentamicin, tobramycin and amikacin among clinical isolates of bacteria.
    Moellering RC, Wennersten C, Kunz LJ, Poitras JW.
    Am J Med; 1977 Jun 30; 62(6):873-81. PubMed ID: 868901
    [Abstract] [Full Text] [Related]

  • 32. Tobramycin and amikacin nephrotoxicity. Value of serum creatinine versus urinary concentration of beta-2-microglobulin.
    Gatell JM, SanMiguel JG, Zamora L, Araujo V, Castells C, Moreno A, Jimenez de Anta MT, Marin JL, Elena M, Ballesta A.
    Nephron; 1985 Jun 30; 41(4):337-43. PubMed ID: 3906418
    [Abstract] [Full Text] [Related]

  • 33. Concentrations of gentamicin and amikacin in human kidneys.
    Edwards CQ, Smith CR, Baughman KL, Rogers JF, Lietman PS.
    Antimicrob Agents Chemother; 1976 Jun 30; 9(6):925-7. PubMed ID: 938022
    [Abstract] [Full Text] [Related]

  • 34. Antimicrobial agents--Part II. The aminoglycosides: streptomycin, kanamycin, gentamicin, tobramycin, amikacin, neomycin.
    Brewer NS.
    Mayo Clin Proc; 1977 Nov 30; 52(11):675-9. PubMed ID: 336988
    [Abstract] [Full Text] [Related]

  • 35. [Pharmacokinetical, histological, and histochemical investigation on the ototoxicity of gentamicin, tobramycin, and amikacin (author's transl)].
    Federspil P, Schätzle W, Tiesler E.
    Arch Otorhinolaryngol; 1977 Jul 29; 217(2):147-66. PubMed ID: 578730
    [Abstract] [Full Text] [Related]

  • 36. Pharmacokinetics of tobramycin and gentamicin in abusers of intravenous drugs.
    King CH, Creger RJ, Ellner JJ.
    Antimicrob Agents Chemother; 1985 Mar 29; 27(3):285-90. PubMed ID: 3994344
    [Abstract] [Full Text] [Related]

  • 37. Clinical pharmacokinetics of amikacin in dogs.
    Baggot JD, Ling GV, Chatfield RC.
    Am J Vet Res; 1985 Aug 29; 46(8):1793-6. PubMed ID: 4037511
    [Abstract] [Full Text] [Related]

  • 38. Comparison of gentamicin and tobramycin nephrotoxicity in patients receiving individualized-pharmacokinetic dosing regimens.
    Pancorbo S, Compty C, Heissler J.
    Biopharm Drug Dispos; 1982 Aug 29; 3(1):83-8. PubMed ID: 7082782
    [Abstract] [Full Text] [Related]

  • 39. The pharmacokinetics of amikacin and gentamicin in volunteers: a comparison of individual differences.
    Walker JM, Wise R, Mitchard M.
    J Antimicrob Chemother; 1979 Jan 29; 5(1):95-9. PubMed ID: 762009
    [No Abstract] [Full Text] [Related]

  • 40. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
    Dámaso D, Moreno-López M, Martínez-Beltrán J, García-Iglesias MC.
    J Infect Dis; 1976 Nov 29; 134 SUPPL():S394-90. PubMed ID: 825591
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.